FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Institute of Clinical and Molecular Virology
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Overview
Publications
(722)
Research Grants
(29)
Project Types
Toggle all
Third Party Funds Group - Overall project
Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third Party Funds Group - Sub project
Third party funded individual grant
Third party funded individual grant
Internally funded project
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project
Non-FAU Project
Status
All
Upcoming
Ongoing
Finished
Project year
From
To
Filters (inactive)
Milk Transmission of Viruses: Prevention of mother to child transmission of Human T-cell leukemia Virus Type 1 (HTLV-1) (Milk-TV)
Nov. 1, 2020 - Oct. 31, 2029
EMOPROM LCN - Multidisziplinäre Online PROMs im Long-COVID Netzwerk von ambulanten, stationären und rehabilitativen Sektoren in Zusammenarbeit mit Patientinnen und Patienten (SO-BMG_EMOPROM LCN)
Nov. 16, 2024 - Nov. 15, 2028
Teilprojekt C5 (GRK 2504 C5)
GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention
Oct. 1, 2019 - Sept. 30, 2028
GRK 2504: Enhancing immunogenicity of Human T-cell leukaemia virus Type 1 (HTLV-1) by interfering with viral transcription (A2) (GRK 2504 A2)
GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504)
Jan. 1, 2019 - Sept. 30, 2028
GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504)
Jan. 1, 2019 - Sept. 30, 2028
HMOs and HTLV-1 (VI-BaCaTec_HMOs and HTLV-1)
Jan. 1, 2025 - June 30, 2026
A094: Host cell factors and nonstructural proteins of SARS-CoV-2
July 1, 2023 - June 30, 2026
P147: Modelling the intestinal barrier to analyse HTLV-1 transmission
Nov. 1, 2024 - April 30, 2026
Aufklärung der Virus-Wirt Interaktion zur Inhibition der Transmission des Humanen T-Zell-Leukämievirus Typ 1 (HTLV-1)
Nov. 1, 2017 - April 30, 2026
A101: Atypical, anti-viral IgG4 antibody responses after SARS-CoV-2 mRNA vaccination
April 1, 2023 - March 31, 2026
‹
1
2
3
›